Trial Profile
A multicenter, double-blind, randomized, placebo controlled comparison of the effects on sexual functioning of extended-release bupropion hydrochloride (300-450mg) and escitalopram (10-20mg) in outpatients with moderate to severe major depression over an eight-week treatment period
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Escitalopram
- Indications Depression; Major depressive disorder
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors GSK
- 04 Nov 2008 Checked against ClinicalTrials.gov record.
- 01 Oct 2005 New trial record.